Make your opinion count. June 21 is the final day for Health Imaging readers to participate in a brief survey and the chance to win a $50 VISA gift card.

The clock is ticking if you want to participate in our brief readership survey and the chance to win a $50 VISA gift card. Cardiovascular Business is asking readers to provide feedback about our website, newsletter and magazine in an effort to provide timely and pertinent information to help you in your career.

Mevion Medical Systems has received FDA 510(k) clearance for the Mevion S250 Proton Therapy System.

The FDA has widened an existing Class 1 recall of a popular infusion pump to include a greater number of units than it previously deemed problematic. The affected product line, Sigmas Spectrum model 35700, may fail to function properly in a number of ways while also failing to issue an alarm.

Browsing this weeks top stories, I am reminded of one of my favorite past covers from Health Imaging & IT magazine. The headline read "Imaging under Fire." In the last week, two major medical journalsthe Journal of the American Medical Association and The Lancetpublished studies that can only be described as combustible.

Intelerad has debuted IntelePACS Breast Imaging module.

Philips Healthcare has introduced the iDose4 Premium Package, which includes two technologies that can improve image qualityiDose4 iterative reconstruction technique, and metal artifact reduction for large orthopedic implants.

Everyone looks for some sort of approval, but where we find it is sometimes a different story. In the case of the transcatheter aortic heart valve, Edwards Lifesciences may be one step closer to finding it after FDAs Circulatory Systems Device Panel voted in favor of expanding device indications to include aortic stenosis patients at a high risk for surgery. While the journey for transcatheter aortic valve replacement (TAVR) has been long, as writer Mark Twain wrote, We can secure other people's approval, if we do right and try hard.